ArticleEndocrine2016

CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.

Poupak Fallahi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.